Montelukast Prescribing at SAFFRON GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,121
Total Quantity
33.3K
NHS Cost
£1.6K
vs National Avg
+63.7%
SAFFRON GROUP PRACTICE prescribed 1,121 items of Montelukast over the last 12 months at a cost of £1,553 to the NHS. This is 63.7% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
103
Jun 2026
79
Jun 2026
95
Jun 2026
89
Jun 2026
93
Jun 2026
102
Jun 2026
101
Jun 2026
95
Jun 2026
88
Jun 2026
92
Jun 2026
84
Jun 2026
100
Prescribing Details
| Total Items | 1,121 |
|---|---|
| Total Quantity | 33,321 |
| Total NHS Cost | £1,553 |
| Presentations | 4 different forms |
| vs National Average | +63.7% |
Montelukast Prescribing Comparison
| This practice | 1,121 items |
|---|---|
| National average per practice | 685 items |
| Difference | +63.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.